Thermo Fisher Scientific Announces "ABgene Plate of the Month”
News Nov 25, 2008
Thermo Fisher Scientific Inc. has announced that it is marking the 2nd century of man-made plastics by providing scientists with valuable ways to trial Thermo Scientific ABgene® PCR and QPCR plates via a Plate of the Month initiative.
The Company explains, When Leo Baekeland invented the world’s first true man-made plastic in 1907, his diary entry stated that he believed that "this invention will prove important in the future." This was definitely an understatement, since man-made plastics have revolutionized life for us all, especially in the field of drug discovery with major advances in PCR and QPCR techniques undertaken using plastic consumables.
‘Our Plate of the Month initiative celebrates not only Baekeland’s achievements, but also those of our own development scientists and manufacturing staff who, over the last 15 years, have contributed by bringing our vast range of high-quality PCR and QPCR plates to the scientific community worldwide –securing our market-leading position,’ according to Thermo Fisher Scientific.
The opening Plate of the Month celebration surrounds the Thermo Scientific low profile ABgene PCR plate (ref AB-0700). The company will give away one case of these low profile PCR plates to the first 10 applicants in November 2008. Subsequent monthly celebrations will focus on other specialist plates within the premium Thermo Scientific ABgene range.
The low profile ABgene® PCR plate has shorter wells than standard PCR plates, making it ideal for use with reaction volumes of less than 20µl. By decreasing the dead space within the well it helps reduce condensation in the well, thus preventing reduction in reaction volume. The plate design incorporates a raised rim around each well for sealing, alphanumeric grid referencing and a cut-away corner for plate orientation.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018